|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Hpatotoxicity of antit - brculosis therapy rifampicin isoniazid and pyrazinamide or viral- hepatitis 显示文摘 | Turktas H Unsal M Tulek N | 1994 | tuberc Lung Dis1994，75，： | 1 |
| 2 | Pulmonary involve- ment in brucellosis显示文摘 | Hatipoglu CA Bilgin G Tulek N | 2005 | J Infect2005，51，2： | 1 |
| 3 | Hepatotoxicity of antituberculosis ther-apy(rifampicjn,isoniazidand and pyrazinamide) or viralhepatitis显示文摘 | Turkatas H Unsal M Tulek N | 1994 | Tuber Lung Dis1994，75，： | 1 |
| 4 | Pulmonary involvement in brucellosis显示文摘 | Hatipoglu CA Bilgin G Tulek N | 2005 | J Infect2005，51，2： | 1 |
| 5 | Bacteriuria, pyuria and bacteremia frequency following outpatient cystoscopy显示文摘 | Turan H Balci U Erdinc F S Tulek N Germiyanogiu C | 2006 | Int J Urol2006，13，： | 1 |
| 6 | Hpatotoxicity of antituberculosis therapy ( rifampicin, isoniazid and apyrazinamide) or viral hepatitis显示文摘 | Turktas H Unsal M Tulek N | 1994 | Tuberc Lung Dis1994，75，1： | 1 |
| 7 | Pulmonary involvement in brucellosis 显示文摘 | Hatipoglu CA Bilgin G Tulek N | 2005 | J Infect2005，51，2： | 1 |
| 8 | Soluble intercellular adhesion molecule-1 (sICAM-1) in patients with systemic lupus erythematosus显示文摘 | Tulek N Aydintug O Ozoran K | 1996 | Clin Rheumatol1996，15，1： | 1 |
| 9 | Soluble interleukin-2 receptor and interleukin-10 levels in patients with chronic hepatitis B infection显示文摘 | Tulek N Saglam SK Saglam M | 2000 | Hepatogastroenterology2000，47，33： | 1 |
| 10 | Hepatotoxicity of an- tituberculosis therapy (rifampicin,isoniazid and pyrazinamide)or viral hepatitis显示文摘 | TURKTAS H UNSAL M TULEK N | 1994 | Tuber Lung Dis1994，75，1： | 1 |
| 11 | Pulmonary involvement in brucellosis显示文摘 | Hatipoglu CA Bilgin G Tulek N | 2005 | J Infect2005，51，2： | 1 |
| 12 | Hepatotoxicity of anti-tuberculosis therapy (rifampicin,isoniazidand and pyrazinamide) or Viral hepatitis显示文摘 | Turktas H Unsal M Tulek N | 1994 | Tuber Lung Dis1994，75，： | 1 |
| 13 | Soluble interleukin-2 receptor and interleukin-10 levels in patients with chronic hepatitis B infection显示文摘 | Tulek N Saglam SK Saglam M | 2000 | Hepatogastroenterology2000，47，33： | 1 |
| 14 | Hepatotoxicity of antituberculosis therapy (rifampicin,isoniazid and pyrazinamide) or viral hepatitis显示文摘 | Turktas H Unsal M Tulek N | 1994 | Tuber Lung Dis1994，75，1： | 1 |
| 15 | A prospective, multi-center study: factors related to the management of diabetic foot infections显示文摘 | Ertugrul BM Oncul O Tulek N | 2012 | Eur J Clin Microbiol Infect Dis2012，31，9： | 1 |
| 16 | Hepatotoxicity of antituberculosis therapy(rifampicin, isoniazid and pyrazinamide)or viral hepatitis显示文摘 | Turktas H Unsal M Tulek N | 1994 | Tuber Lung Dis1994，75，1： | 1 |
| 17 | Hpalolokicity of antituberculosis therapy(rifampicin,isoniazid and pyrazinamide) or viral hepatitis显示文摘 | Turktas H Unsal M Tulek N | 1994 | Tuberc Lung Dis1994，75，： | 1 |
| 18 | Pulmonary involvement in brucellosis显示文摘 | Hatipoglu CA Bilgin G Tulek N | | 0，，02： | 1 |
| 19 | Hpatotoxicity of antituberculosis therapy(rifampicin isoniazidand and pyrazinamide)or viral hepatitis显示文摘 | Turktas H Unsal M Tulek N | 1994 | Tuberc Lung Dis1994，75，1： | 1 |
| 20 | Hepatotoxicity of antituberculosis therapy (rifampicin,isoniazid and pyrazinamide) or viral hepatitis显示文摘 | Turktas H Unsal M Tulek N | 1994 | Tuber Lung Dis1994，75，： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员